BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18637442)

  • 1. [Prognostic molecular markers in oral and lip squamous cell carcinoma--evaluation of expression and its significance].
    Jaworska M; Kołosza Z; Liszka J; Nikiel B; Goleń M; Lange D; Scierski W; Namysłowski G
    Otolaryngol Pol; 2008; 62(2):175-81. PubMed ID: 18637442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma.
    Perisanidis C; Perisanidis B; Wrba F; Brandstetter A; El Gazzar S; Papadogeorgakis N; Seemann R; Ewers R; Kyzas PA; Filipits M
    J Oral Pathol Med; 2012 Jan; 41(1):40-6. PubMed ID: 21883486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma.
    Mielcarek-Kuchta D; Olofsson J; Golusinski W
    Eur Arch Otorhinolaryngol; 2003 Nov; 260(10):549-54. PubMed ID: 14551784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
    Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the effect of accelerated fractionation in postoperative radiotherapy for head and neck cancer based on molecular marker profiles: data from a randomized clinical trial.
    Suwinski R; Jaworska M; Nikiel B; Grzegorz W; Bankowska-Wozniak M; Wojciech M; Krzysztof S; Dariusz L
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):438-46. PubMed ID: 19733016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of cyclin D1 and interaction between p27Kip1 and tumour thickness predict lymph node metastases occurrence in lower lip squamous cell carcinoma.
    Rodolico V; Aragona F; Cabibi D; Di Bernardo C; Di Lorenzo R; Gebbia N; Gulotta G; Leonardi V; Ajello F
    Oral Oncol; 2005 Mar; 41(3):268-75. PubMed ID: 15743689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance.
    Carlos de Vicente J; Herrero-Zapatero A; Fresno MF; López-Arranz JS
    Oral Oncol; 2002 Apr; 38(3):301-8. PubMed ID: 11978554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue.
    Bova RJ; Quinn DI; Nankervis JS; Cole IE; Sheridan BF; Jensen MJ; Morgan GJ; Hughes CJ; Sutherland RL
    Clin Cancer Res; 1999 Oct; 5(10):2810-9. PubMed ID: 10537346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of laminin-5 in oral dysplasia and squamous cell carcinoma.
    Rani V; McCullough M; Chandu A
    J Oral Maxillofac Surg; 2013 Nov; 71(11):1873-9. PubMed ID: 23891017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.
    Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
    J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal Ki67 expression measured by digital image analysis is optimal for prognostication in oral squamous cell carcinoma.
    Klimowicz AC; Bose P; Nakoneshny SC; Dean M; Huang L; Chandarana S; Magliocco AM; Wayne Matthews T; Brockton NT; Dort JC
    Eur J Cancer; 2012 Sep; 48(14):2166-74. PubMed ID: 22892062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki-67, cyclin D1, p53 and bcl-2 expression in advanced head and neck cancer.
    Nagy B; Tiszlavicz L; Eller J; Molnar J; Thurzo L
    In Vivo; 2003; 17(1):93-6. PubMed ID: 12655798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 overexpression in primary hypopharyngeal carcinomas.
    Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S
    Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment tumor markers by immunohistochemistry (Ki67, p53 and Bcl-2) on a cohort of patients with cervical cancer in various stages of evolution].
    Stoenescu TM; Ivan LD; Stoenescu N; Azoicăi D
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):485-92. PubMed ID: 21870745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
    Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S
    J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
    Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
    J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
    Nemes JA; Nemes Z; Márton IJ
    J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostics of Cyclin-D1 expression with chemoradiation response in patients of locally advanced oral squamous cell carcinoma.
    Khan H; Gupta S; Husain N; Misra S; Singh N; Negi MP
    J Cancer Res Ther; 2014; 10(2):258-64. PubMed ID: 25022375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 is a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma.
    Samejima R; Kitajima Y; Yunotani S; Miyazaki K
    Anticancer Res; 1999; 19(6C):5515-21. PubMed ID: 10697609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.